MaxCyte Inc (MXCT) financials · rev $33.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
MaxCyte Inc (MXCT) rev $33.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $33.0M | $38.6M |
| Cost of Revenue | $6.22M | $7.10M |
| Gross Profit | $26.8M | $31.5M |
| Operating Income | -$51.9M | -$51.2M |
| Net Income | -$44.6M | -$41.1M |
| EPS (Diluted) | -$0.42 | -$0.39 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $202.5M | $239.5M |
| Current Assets | $118.4M | $171.7M |
| Cash & Equivalents | $20.1M | $27.9M |
| Inventory | $7.55M | $8.91M |
| PP&E | $17.5M | $19.7M |
| Total Liabilities | $31.0M | $33.2M |
| Current Liabilities | $14.3M | $15.8M |
| Shareholders' Equity | $171.5M | $206.3M |
| Retained Earnings | -$261.5M | -$216.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$34.4M | -$27.6M |
| CapEx | $1.77M | $1.65M |
| Investing Cash Flow | $25.9M | $6.93M |
| Financing Cash Flow | $656.0K | $2.06M |
| Net Change in Cash | -$7.82M | -$18.6M |
| Free Cash Flow | -$36.2M | -$29.3M |
FAQ
What is MXCT P/E and revenue?
MaxCyte Inc (MXCT) rev $33.0M.
What is MXCT revenue?
MaxCyte Inc last cached revenue is $33.0M (FY2025).
Is MXCT profitable?
MaxCyte Inc last cached net income is -$44.6M (FY2025).
What are MXCT total assets?
MaxCyte Inc last cached total assets are $202.5M (FY2025).
What is MXCT free cash flow?
MaxCyte Inc last cached free cash flow is -$36.2M (FY2025).
Not investment advice. Cached statements, not a live tape.